| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |